Published in J Hyg (Lond) on October 01, 1982
Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin Vaccine Immunol (2011) 1.57
The postnatal acquisition of factors which affect the influenza haemagglutination-inhibition test. J Hyg (Lond) (1982) 0.81
Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns. Acta Obstet Gynecol Scand (2015) 0.77
Antibody against viruses in maternal and cord sera: non-specific inhibitors are found to higher titre on the maternal side of the circulation. J Hyg (Lond) (1984) 0.75
THE ELECTROPHORETIC ANALYSIS OF MATERNAL AND FETAL PLASMAS AND SERA. J Clin Invest (1945) 2.66
A single radial haemolysis technique for the measurement of influenza antibody. J Gen Virol (1975) 2.62
Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport. Nature (1966) 2.37
The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. J Hyg (Lond) (1979) 1.65
The placental transfer of IgG subclasses in human pregnancy. Clin Exp Immunol (1980) 1.38
A prospective study of primary cytomegalovirus infection in pregnant women. Br J Obstet Gynaecol (1980) 1.31
Maternal antibodies in human foetal sera at different stages of gestation. Immunology (1968) 1.29
A comparative study of methods used for removing non-specific inhibitors of rubella haemagglutination from human sera. Med Lab Technol (1975) 1.16
Placental passage of antibodies to Dengue virus in persons living in a region of hyperendemic Dengue virus infection. J Infect Dis (1975) 1.11
A prospective study of influenza infections during pregnancy. J Epidemiol Community Health (1980) 1.04
Comparison of maternal and cord serum titres for measles and for rubella antibodies. Arch Gesamte Virusforsch (1974) 1.02
Haemagglutination-inhibition antibodies against influenza A and influenza B in maternal and neonatal sera. J Hyg (Lond) (1978) 1.01
Maternal antibodies in human neonatal sera. Immunology (1970) 0.99
Influenza and corona-virus antibodies in the newborns and their mothers in Mali (1980). Tropenmed Parasitol (1980) 0.98
Complement fixation and neutralization RS antibodies in maternal and neonatal sera. J Hyg (Lond) (1977) 0.80
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet (2000) 4.67
The pathogenesis of Sendai virus infection in the mouse lung. J Med Microbiol (1968) 3.35
Open access clinic providing HIV-I antibody results on day of testing: the first twelve months. BMJ (1991) 3.17
Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci. Lancet (1984) 2.65
Inhibitory effects of urine on the polymerase chain reaction for cytomegalovirus DNA. J Clin Pathol (1991) 2.53
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
Unilateral leptomeningeal enhancement after carotid stent insertion detected by magnetic resonance imaging. Stroke (2000) 2.33
Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet (1989) 2.23
The dynamics of human cytomegalovirus replication in vivo. J Exp Med (1999) 2.19
Neuroimaging for non-accidental head injury in childhood: a proposed protocol. Clin Radiol (2003) 2.15
Comparison of Doppler ultrasound, magnetic resonance angiographic techniques and catheter angiography in evaluation of carotid stenosis. Clin Radiol (2000) 2.11
Frequency and natural history of subdural haemorrhages in babies and relation to obstetric factors. Lancet (2004) 2.09
The effect of cyclophosphamide on Sendai virus infection of mice. J Med Microbiol (1969) 2.08
Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics (1982) 2.07
Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease. Lancet (1994) 2.05
On-line acquisition of the output of AutoAnalyzers. J Clin Pathol (1969) 1.96
Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet (1987) 1.89
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis (1998) 1.88
The natural history of human immunodeficiency virus infection in a haemophilic cohort. Br J Haematol (1989) 1.84
Comparison of ultrasound and magnetic resonance imaging in 100 singleton pregnancies with suspected brain abnormalities. BJOG (2004) 1.83
Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet (1997) 1.83
Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. J Infect Dis (1997) 1.77
HHV-6 in AIDS. Lancet (1994) 1.76
Investigating the functional anatomy of empathy and forgiveness. Neuroreport (2001) 1.69
Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS (1997) 1.68
Noise levels in a clinical chemistry laboratory. J Clin Pathol (1970) 1.68
Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections. J Infect Dis (1983) 1.67
The pathogenesis of infections of the mouse caused by virulent and avirulent variants of an influenza virus. J Med Microbiol (1975) 1.65
Use of monoclonal antibodies for the diagnosis of cytomegalovirus infection by the detection of early antigen fluorescent foci (DEAFF) in cell culture. J Med Virol (1987) 1.65
Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol (2002) 1.63
Serum levels of ATP: creatine phosphotransferase (creatine kinase). The normal range and effect of muscular activity. Clin Chim Acta (1966) 1.59
Effect of cyclophosphamide on infections in mice caused by virulent and avirulent strains of influenza virus. Infect Immun (1975) 1.59
Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease. Bone Marrow Transplant (1998) 1.58
Spinal-cord involvement in diabetic peripheral neuropathy. Lancet (2001) 1.57
Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection. AIDS (1992) 1.56
Involvement of the anterior lobe of the cerebellar vermis in perinatal profound hypoxia. AJNR Am J Neuroradiol (2007) 1.55
The effects of dehydration on brain volume -- preliminary results. Int J Sports Med (2005) 1.55
The detection of rubella-specific IgM antibodies by radioimmunoassay. Br J Exp Pathol (1978) 1.54
HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor. Nature (1990) 1.52
Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody. J Clin Pathol (1982) 1.47
Serum enzymes in diseases of the thyroid gland. J Clin Pathol (1965) 1.46
Studies of the immune respnse in Sendai virus infection of mice. J Med Microbiol (1971) 1.45
Acute pancreatitis and diabetic ketoacidosis in accidental hypothermia and hypothermic myxoedema. Br Med J (1973) 1.45
Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain (2000) 1.45
Studies on the immune response and pathogenesis of Sendai virus infection of mice. I. The fate of viral antigens. Immunology (1972) 1.44
Beta 2 microglobulin enhances the infectivity of cytomegalovirus and when bound to the virus enables class I HLA molecules to be used as a virus receptor. J Gen Virol (1987) 1.44
Serum-enzymes in relation to electrocardiographic changes in accidental hypothermia. Lancet (1968) 1.43
Viral burden in HIV infection. Nature (1994) 1.43
Progress towards interrupting intrauterine transmission of cytomegalovirus? Rev Med Virol (2005) 1.42
Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet (1988) 1.41
Choice of cross size in stereology--a cautionary note. Neuroradiology (2003) 1.39
A prospective study of primary cytomegalovirus infection during pregnancy: final report. Br J Obstet Gynaecol (1984) 1.38
Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J Gen Virol (1992) 1.38
Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis (2004) 1.35
An improved radioimmunoassay method for the detection of IgG antibodies against cytomegalovirus. J Virol Methods (1986) 1.35
Simplified quantification of urinary protein excretion in children. Clin Nephrol (1988) 1.35
Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus. J Gen Virol (1991) 1.34
Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis (1999) 1.34
Cytomegalovirus strain AD169 binds beta 2 microglobulin in vitro after release from cells. J Gen Virol (1987) 1.32
A prospective study of primary cytomegalovirus infection in pregnant women. Br J Obstet Gynaecol (1980) 1.31
Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases. BMJ (1996) 1.31
Intracranial MR venography in children: normal anatomy and variations. AJNR Am J Neuroradiol (2004) 1.31
Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am J Obstet Gynecol (1988) 1.30
A comparison of complement fixation, indirect immunofluorescence for viral late antigens, and anti-complement immunofluorescence tests for the detection of cytomegalovirus specific serum antibodies. J Clin Pathol (1978) 1.30
Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy. Proc Natl Acad Sci U S A (2000) 1.30
Clinical chemistry usage in Britain and Canada. N Engl J Med (1980) 1.30
Infection with cytomegalovirus during pregnancy: specific IgM antibodies as a marker of recent primary infection. J Infect Dis (1982) 1.30
Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet (1986) 1.29
MR imaging and spectroscopy in Lhermitte-Duclos disease. Neuroradiology (2004) 1.29
Coxsackie B virus infections and myocardial infarction. Results from a prospective, epidemiologically controlled study. Lancet (1980) 1.27
Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology (2004) 1.26
Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J Gen Virol (1995) 1.26
A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease. Gastroenterology (1990) 1.24
Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation. Am J Transplant (2008) 1.24
Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. Br J Cancer (1993) 1.24
Tethering of the vertebral artery in the congenital arcuate foramen of the atlas vertebra: a possible cause of vertebral artery dissection in children. Dev Med Child Neurol (2001) 1.23
Quantification of human herpesvirus 6 in immunocompetent persons and post-mortem tissues from AIDS patients by PCR. J Gen Virol (1996) 1.22
Summary of the II International Symposium on Cytomegalovirus. Antiviral Res (1998) 1.21
Modified latex agglutination test for anticytomegalovirus, suitable for pretransfusion screening. J Clin Pathol (1987) 1.20
Anonymous testing of women attending antenatal clinics for evidence of infection with HIV. Lancet (1988) 1.20
Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation. Am J Transplant (2008) 1.19
Molecular biology and immunology of cytomegalovirus. Biochem J (1987) 1.19
Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy. Am J Transplant (2012) 1.19
Symptomless HIV infection after more than ten years. Lancet (1990) 1.18
HSV shedding. Antiviral Res (2004) 1.18
Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction. J Infect Dis (1996) 1.17
A comparative study of methods used for removing non-specific inhibitors of rubella haemagglutination from human sera. Med Lab Technol (1975) 1.16
Sickle cell disease and silent avascular necrosis of the hip. J Bone Joint Surg Br (1991) 1.16
Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation. J Med Virol (1997) 1.15
Population dynamics of HIV within an individual after treatment with zidovudine. AIDS (1991) 1.15
Detection of subarachnoid haemorrhage with magnetic resonance imaging. J Neurol Neurosurg Psychiatry (2001) 1.15
Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis. AIDS (1998) 1.13
Chlamydia, cytomegalovirus, and Yersinia in inflammatory bowel disease. Lancet (1979) 1.13
Specific patterns of cognitive impairment in patients with idiopathic normal pressure hydrocephalus and Alzheimer's disease: a pilot study. J Neurol Neurosurg Psychiatry (1999) 1.12
Cell-mediated immunity to Sendai virus infection in mice. Infect Immun (1977) 1.12
Studies on the immune response and pathogenesis of Sendai virus infection of mice. II. The immunoglobulin class of plasma cells in the bronchial sub-mucosa. Immunology (1974) 1.12